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ABSTRACT
We have developed an effective, easy-to-use
two-step system for the site-directed insertion of
large genetic constructs into arbitrary positions in
the Escherichia coli chromosome. The system
uses j-Red mediated recombineering accompanied
by the introduction of double-strand DNA breaks in
the chromosome and a donor plasmid bearing the
desired insertion fragment. Our method, in contrast
to existing recombineering or phage-derived inser-
tion methods, allows for the insertion of very large
fragments into any desired location and in any ori-
entation. We demonstrate this method by inserting a
7-kb fragment consisting of a venus-tagged lac
repressor gene along with a target lacZ reporter
into six unique sites distributed symmetrically
about the chromosome. We also demonstrate the
universality and repeatability of the method by sep-
arately inserting the lac repressor gene and the lacZ
target into the chromosome at separate locations
around the chromosome via repeated application
of the protocol.
INTRODUCTION
The ability to engineer plasmid constructs containing
genetic elements of arbitrary complexity has transformed
biology. The use of engineered plasmids has become ubiq-
uitous as a way to controllably express and study genes and
gene networks, and has proven to be an indispensable tool
for determining the function of many gene products. While
proving extraordinarily useful, problems with copy
number, DNA size and stability often arise. For example,
plasmids and bacterial artiﬁcial chromosomes (BACs) are
generally maintained in multiple copies, with copy
numbers ranging over several orders of magnitude
(1–1000), depending on the replication origin. Average
plasmid copy numbers can also be aﬀected by the growth
state of the cell (1), and even when maintained at constant
growth conditions, cell-to-cell plasmid copy number ﬂuc-
tuations can be substantial (2). While the systematic vari-
ation of average plasmid copy number and copy number
ﬂuctuations have been studied extensively for a few
systems, for the majority of plasmid replication origins it
is unknown how copy number depends on the growth state
of the cell, and how much cell to cell variation there is. This
can lead to problems with the interpretation of experimen-
tal data, for example, in measurements of noise in gene
expression (3), because the magnitude and eﬀects of these
ﬂuctuations are almost completely unknown.
Thus, it is advantageous to incorporate constructs
directly into the chromosome where the construct can be
stably maintained without the need for antibiotic selec-
tion. While the position of the insertion relative to the
replication origin can still lead to cell-to-cell copy
number variability because of multiple replication forks,
this variability is systematic, well understood (4), and can
be corrected for or exploited.
Unfortunately, it remains diﬃcult to insert large DNA
segments into the Escherichia coli chromosome. Currently,
there are two main approaches to chromosomal integra-
tion: recombineering (5–11) and phage-derived methods
(12). Recombineering is highly eﬀective and easy to use,
involving the expression of  -Red enzymes in order to
promote site-speciﬁc homologous recombination between
the chromosome and a small linear polymerase chain
reaction (PCR) fragment containing the desired
sequence. By amplifying the linear fragment using
primers, which contain 40–50-bp ﬂanking regions homol-
ogous to the sequence of the desired insertion site,
recombineering allows great ﬂexibility in designing and
choosing the chromosomal location and orientation. In
addition, once the construct has been created, it can be
inserted into various locations by designing new primers
with the appropriate homology regions. Despite these
advantages, recombineering in E. coli suﬀers from
several shortcomings. For large fragments, it becomes
increasingly diﬃcult to generate PCR product in suﬃcient
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transformation and integration signiﬁcantly less eﬃcient.
As a representative example, the number of recombinants
we obtain when deleting lacZ with progressively larger
PCR fragments bearing 50-bp homology extensions is
illustrated in Figure 1 (6). Other laboratories have
reported the successful and reliable integration of frag-
ments up to  3.5kb (13–16). In addition, integration eﬃ-
ciency can be enhanced by another order of magnitude by
including homology regions 1kb or larger (7). However,
this generally requires the engineering of plasmid con-
structs bearing unique homology arms for each individual
insertion fragment or location. Further restricting this
approach is the general requirement to include an antibi-
otic marker on the inserted fragment to allow for the selec-
tion of successful integrants, occupying valuable real
estate on the recombinant fragment. Because of these lim-
itations, the insertion of large fragments into speciﬁc sites
on the chromosome remains a non-trivial task.
An alternative approach uses phage-integration systems
to facilitate the insertion of synthetic constructs into the
chromosome (12,17). Here, the donor plasmid contains a
phage-speciﬁc attachment site (attP), which, when trans-
formed into a host cell expressing the appropriate phage
integrase enzyme, is integrated into complementary phage
attB attachment sites in the chromosome. These
phage-based systems have many advantages: they are
highly eﬃcient (17), and, in some instances, when the
appropriate phage xis enzyme is expressed, the constructs
canalsobeeasilyremoved(12).Perhapsthegreatestadvan-
tage of the phage-based systems is that there is eﬀectively
no limit to the size of the fragment that can be inserted at
the attachment site. However, these approaches also have
many disadvantages. Chief among these is the requirement
for unique constructs to insert the same fragment into
multiple diﬀerent locations, since for each desired insertion
locationanewconstructmustbemadebearingtherequired
phage attP site. In addition, as the phage systems currently
in widespread use in E. coli utilize endogenous
chromosomal attachment sites, ﬂexibility in choosing the
insertion location is drastically reduced.
Recently, several groups have exploited the fact that
double-strand DNA breaks stimulate in vivo recombina-
tion, thereby facilitating the high-throughput construction
of plasmid libraries [MAGIC (18)], the subcloning of large
fragments into BACs [ALFIRE (19)], or the recombina-
tion of short DNA fragments to introduce or repair muta-
tions within the chromosome [gene gorging (20)]. These
techniques utilize the yeast mitochondrial homing
endonuclease I-SceI to introduce double strand breaks in
the donor and/or recipient DNA molecule to enhance
site-speciﬁc recombination. As the large 18-bp I-SceI rec-
ognition site does not exist naturally within the E. coli
chromosome, introduction and cleavage of the recognition
site at the desired location enhances site-speciﬁc recombi-
nation by several orders of magnitude (18) without any
additional chromosomal damage.
Here, we describe a method for the chromosomal inser-
tion of constructs that circumvents the limitations on
insert size and location described above. To accomplish
this, the cell is ﬁrst transformed with a helper plasmid,
pTKRED, harboring genes encoding the  -Red enzymes,
I-SceI endonuclease, and RecA.  -Red enzymes expressed
from the helper plasmid are used to recombineer a small
(1.3kb) ‘landing pad’, a tetracycline resistance gene (tetA)
ﬂanked by I-SceI recognition sites and 25-bp landing pad
regions, into the desired location in the chromosome.
After tetracycline selection for successful landing pad
integrants, the cell is transformed with a donor plasmid
carrying the desired insertion fragment; this fragment is
excised by I-SceI and incorporated into the landing pad
via recombination at the landing pad regions. In this
manner, very large constructs can be inserted at any
desired location within the chromosome. After success-
ful integration, the I-SceI recognition sites in both the
landing pad and the inserted fragment are eliminated,
allowing successive applications of this protocol without
modiﬁcation of the landing pad regions. The entire proce-
dure, from start to veriﬁed product, takes  1.5–2 weeks.
This method has proven to be very easy to use and highly
successful, allowing us to insert large (7kb) fragments into
several chromosomal locations without a single failure.
MATERIALS AND METHODS
Strains and Plasmids
StrainsusedwereE.coliK-12MG1655(ColiGeneticStock
Center) in which the lac operon has been deleted by the
method of Datsenko and Wanner (6) from the N terminal
coding sequence of lacI to the C terminal coding sequence
of lacA (henceforth denoted MG1655 lac, unless noted
otherwise). Annotated sequences of pTKRED, pTKS/CS,
and pTKIP versions are available as Genbank accession
numbers GU327533, GU327534, GU327535, GU327536,
GU327537, and GU327538 respectively).
Construction of the helper plasmid pTKRED
All PCRs were performed using Phusion Hi-Fi master mix
(Finnzymes) and the sequences for all primers are listed in
Figure 1. Representative recombineering eﬃciency as a function of
insert size. 1000–4500-bp inserts containing the neo gene and bearing
50-bp ﬂanking homology regions were inserted into the lacZ gene of
strain K-12 MG1655 pTKRED via the method of Datsenko and
Wanner (6). Cells were plated on LB agar+25mg/ml kanamycin,
and the number of successful recombinants quantiﬁed as the number
of resulting white colonies.
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was constructed using the MAGIC plasmid pML104,
the kind gift of Dr Steven Elledge (18), which contains
the  -Red enzymes under the control of a LacI regulated
promoter, as well as constitutively expressed RecA.
The I-SceI gene was ampliﬁed from the MAGIC strain
BUN21 (18) and puriﬁed. An araC-ParaC-ParaBAD
fragment was ampliﬁed from the plasmid pKD46 (6)
using a 30 primer with an extension homologous to the
50 sequence of the I-SceI gene. This araC fragment was
puriﬁed and fused to the I-SceI gene in a fusion PCR
reaction. The resulting araC-ParaC-ParaBAD-I-SceI
fragment was gel-purifed (using QIAEX II) and ligated
into the SphI site of pML104, to create pTKRED-I. The
lac repressor, along with its native promoter PlacI, was
ampliﬁed from K-12 MG1655 and ligated into the NheI
site of pTKRED-I, creating pTKRED.
Dependence of recombineering eﬃciency on insert size
The size-dependent eﬃciency of linear PCR fragment
recombineering was assayed using the recombineering
template pL451 (9), from which 1000–4500-bp fragments
varying in length by 500-bp increments and containing the
neo gene were prepared by PCR. These fragments were
then used to transform competent MG1655 pTKRED,
according to the method of Datsenko and Wanner (6).
Competent cells were prepared in super optimal broth
(SOB) medium supplemented with 0.5% w/v glucose and
100mg/ml spectinomycin; 2mM IPTG was added with the
initial inoculum to induce expression of  -Red enzymes.
An identical culture was prepared in parallel without
isopropyl b-D-1-thiogalactopyranoside (IPTG) to serve
as a negative control. Once the OD (l=600nm) of the
culture reached  0.5–0.6, the cells were placed on ice and
washed 3  with ice-cold 10% v/v glycerol. One-hundred
microliters of the resulting competent cells was added to
 100ng of puriﬁed PCR fragment and the resulting
mixture was electroporated in 0.1-cm-gap cuvettes (USA
Scientiﬁc) at 2.0kV, 25uF, 200X in a Gene Pulser
electroporation apparatus (BioRad). Cells were
resuspended in 1ml SOC medium. The cells were
allowed to recover at room temperature for 24h, and
then plated on LB agar plates with 25mg/ml kanamycin,
0.1% X-Gal and 2mM IPTG and incubated overnight at
37 C. The number of successful recombinants was the
number of white colonies per plate.
Construction of the donor plasmid pTKIP
Two unique, random 25-bp sequences with  50% GC
content were generated using a random sequence genera-
tor in MATLAB (MathWorks). The resulting sequences
were BLASTed against the E. coli genome to ensure their
uniqueness. The sequences obtained in this way and used
throughout this communication were landing pad region
1: 50-TACGGCCCCAAGGTCCAAACGGTGA-30;
landing pad region 2: 50-GATGGCGCCTCATCCCTGA
AGCCAA-30. To generate the donor plasmid pTKIP,
primers containing I-SceI recognition sites were used to
amplify the pBR322 backbone containing the bla
ampicillin resistance gene and the pMB1 replication
origin. Primers containing I-SceI sites, as well as the
25-bp landing pad regions given above, were used
to amplify the multiple cloning site (MCS) and neo resis-
tance gene from the recombineering plasmid pL451 (9).
Both the backbone and fragment were digested with
I-SceI (New England Biosciences), gel puriﬁed and
ligated together. The resulting insertion platform
includes a bla ampicillin resistance marker in the
backbone for simpliﬁed screening against clones retaining
pTKIP after insertion.
Several versions of the pTKIP plasmid were generated
containing antibiotic resistance genes within the insertion
fragment: neo (kanamycin resistance from pL451), cat
[chloramphenicol resistance; ampliﬁed from pZA31-luc
(21)], dhfr [trimethoprim resistance; ampliﬁed from
pAH145 (12)] or hph [hygromycin B resistance; ampliﬁed
from p220KattBfull (17)], the kind gift of Dr Michele
Calos]. These alternate versions of pTKIP were generated
using recombineering to exactly replace the neo gene of
pTKIP-neo in SW105 (11). These plasmids contain the
indicated antibiotic resistance genes ﬂanked by ﬂippase
recognition target (FRT) sites. After successful integra-
tion, the resistance genes can be eliminated via expression
of ﬂippase recombination enzyme (FLP) recombinase
from e.g. pCP20 (6).
Construction of insertion fragment
A 7-kb regulatory unit consisting of a lacI:venus
translational fusion and a lacZ reporter gene was con-
structed to test the eﬃcacy of the insertion method.
A T1 Rho-independent terminator was ampliﬁed from
pZA31-luc (21) and puriﬁed. A PlacI-lacI:venus fusion
was then ampliﬁed from strain JE13, the kind gift of Dr
Sunney Xie (22), using primers with an overlap extension
homologous to the previously ampliﬁed T1 terminator.
lacI:venus and the T1 terminator were then coupled
together in a fusion PCR reaction and inserted into the
KpnI and SalI sites of pTKIP-neo, yielding pTKIP-IvT.
The insertion fragment is referred to throughout as the
IvT-neo cassette. Primers including a PLlacO1 promoter
(21) were then used to amplify lacZ from MG1655,
which was subsequently inserted into the HindIII and
NheI sites of pTKIP-IvT to yield pTKIP-IvT-O1Z. This
large fragment is referred to throughout as the IvT-O1Z-
neo cassette. To test the repeatability of the protocol, an
additional construct was made carrying only PLlacO1-lacZ
on plasmid pTKIP-cat without the lacI:venus:T1 regula-
tor. This insertion fragment is referred to as the O1Z-cat
cassette.
Construction of the landing pad plasmid pTKS/CS
pTKS/CS was generated using the technique described
above for pTKIP. A backbone including the cat
chloramphenicol resistance gene and a p15A replication
origin was ampliﬁed from pZA31-luc (21) using primers
containing the 25-bp landing pad regions as well as I-SceI
recognition sites. Primers containing I-SceI recognition
sites and the promoter PlacIQ1 (23) were used to amplify
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ments were digested with I-SceI and ligated together,
yielding pTKS/CS. This plasmid contains the tetA tetra-
cycline resistance gene ﬂanked by the 25-bp landing pad
regions and I-SceI recognition sites, and is used as a PCR
template for the preparation of linear landing pad frag-
ments for recombineering. The cat gene in the backbone
can be used to screen successful landing pad integrants
from cells transformed by undigested pTKS/CS.
Landing pad integration
pTKS/CS was used as a PCR template to amplify landing
pad fragments using the landing pad regions as
standardized priming sites. The primers included 50-bp
sequence homology for the desired insertion location in
the chromosome. PCR conditions were as follows: 95 C
for 30s, followed by 35 cycles of 98 C for 15s, 55 C for
15s and 72 C for 30s. The resulting PCR reactions were
digested with 1ml DpnI per 50ml PCR reaction for at least
2h at 37 C and puriﬁed using a QIAquick spin column.
Cells containing pTKRED were prepared and
electroporated with  100ng of puriﬁed landing pad
fragment as detailed earlier. After electroporation, 1ml
SOC medium was added. After recovery for at least 2h,
500ml was plated on LB agar plates containing 10mg/ml
tetracycline, 100mg/ml spectinomycin and 0.5% glucose
and grown overnight at 30 C. The remaining  500ml
was allowed to recover overnight and plated the next
day. Potential integrants were picked onto LB plates sup-
plemented with 34mg/ml chloramphenicol to screen
against colonies which had been transformed with
undigested pTKS/CS plasmid. The high level of expres-
sion from the PlacIQ1 promoter combined with the
signiﬁcantly decreased growth rate of cells expressing
tetA (24) makes it easy to distinguish landing pad
integrants from higher copy number pTKS/CS
transformants, and, consequently, all potential integrants
passed this screen. We also veriﬁed that chromosomal
landing pad integrants cannot grow on low nutrient LB
agar plates supplemented with fusaric acid (25). Samples
were veriﬁed by colony PCR across the desired insertion
junctions.
Fragment insertion
Individual colonies were inoculated into 5ml of EZ-Rich
Deﬁned Medium (RDM; Teknova) +0.5% glycerol,
2mM IPTG, and 0.2% w/v L-arabinose. After growing
at 37 C for 1h in a shaking water bath (New Brunswick
Scientiﬁc), 100mg/ml spectinomycin was added to the
culture and the tubes were transferred to a 30 C shaking
water bath for 4h. The appropriate antibiotic for the given
insertion fragment was then added (25mg/ml kanamycin,
34mg/ml chloramphenicol, 100mg/ml hygromycin or
300mg/ml trimethoprim), and the cultures were grown
overnight. The next day, samples were diluted 10
5  and
100ml was plated on LB plates with the appropriate anti-
biotic and grown at 37 C. Potential integrants were picked
and screened on LB plates containing 100mg/ml ampicillin
or 10mg/ml tetracycline to verify the loss of the landing
pad and donor plasmid. Clones passing this screen were
again veriﬁed by colony PCR across the integration
junction, and the resulting PCR fragments were sequenced
(Genewiz).
Curing of pTKRED
Veriﬁed clones containing the desired fragment were
picked into 5-ml LB and grown overnight in a shaking
water bath at 42 C. The next day, samples were diluted
10
5  and 100ml was plated on LB agar plates and grown
at 37 C. Colonies were then picked onto 100mg/ml
spectinomycin LB agar plates to verify loss of pTKRED.
Elimination of antibiotic resistance genes
After elimination of pTKRED, cells were transformed
with pCP20 (6), which constitutively expresses FLP
recombinase. Individual colonies were picked into 5-ml
LB and grown overnight at 42 C. Samples were diluted
10
5 , and 100ml of this dilution was plated on LB agar
plates and grown overnight at 37 C. Colonies were
screened against the retention of pCP20 and the
chromosomally incorporated antibiotic marker. All
colonies tested had lost both pCP20 and the chromosomal
antibiotic marker.
RESULTS
Strategy
The three plasmids used in the protocol are diagrammed
in Figure 2a, and the general strategy is outlined in
Figure 2c. The ﬁrst step is the transformation of the
desired host strain with the helper plasmid pTKRED, con-
taining the spectinomycin resistance marker aadA.
pTKRED carries the genes and regulatory elements nec-
essary for all downstream steps, including a constitutively
expressed recA gene and the three  -Red genes gam, bet
and exo driven by a LacI regulated, IPTG inducible
promoter. These genes are necessary for the integration
of a landing pad at the desired integration site and the
enhancement of fragment insertion via recombination.
The constitutive expression of RecA allows for eﬃcient
recombineering of recA
  host strains, such as the
common laboratory strain DH5a (7). In addition,
pTKRED harbors a ParaBAD-driven I-SceI gene inducible
with L-arabinose. pTKRED bears a temperature-sensitive
pSC101 replication origin, which maintains the plasmid at
low copy number and allows for easy curing by growth at
42 C and screening against spectinomycin resistance.
Next, pTKS/CS is used as a PCR template to amplify a
small 1.3-kb landing pad, consisting of a tetA tetracycline
resistance gene ﬂanked by I-SceI endonuclease recognition
sites and small 25-bp landing pad regions. The small size
of this construct allows the simple and reliable insertion of
the landing pad into any location using previously estab-
lished recombineering methods (6,7,10). tetA allows for
both the easy selection of successful tetracycline-resistant
integrants and later counterselection against landing pad
retention using fusaric acid or nickel salts (25–27) after
I-SceI stimulated replacement of the landing pad.
However, in our hands the process has proven suﬃciently
e92 Nucleic Acids Research, 2010,Vol. 38,No. 6 PAGE 4 OF 10Figure 2. (a) Plasmids used in the integration protocol. The sequence size given is for pTKIP-neo; neo is exactly replaced with various antibiotic
resistance genes for alternate versions of pTKIP. Small green boxes are I-SceI restriction sites; landing pad regions 1 and 2 are small red boxes
labeled LP1 and LP2 respectively. (b) Annotated sequence of the pTKIP MCS showing LP1, available restriction sites, and the ﬁrst four bases of the
adjacent FRT site. (c) Strategy for large construct chromosomal integration. Step 1: the host strain is transformed with the helper plasmid pTKRED,
bearing I-SceI endonuclease (green) and  -Red (red). Linear landing pad fragments (yellow) are integrated into the chromosome at the desired
location (black squares) when  -Red expression is induced by IPTG. Step 2: the host strain is transformed with pTKIP bearing the fragment (purple)
to be inserted into the landing pad. I-SceI expression is induced via the addition of L-arabinose, and the I-SceI recognition sites (green) in the donor
plasmid and chromosome are cleaved. Integration of the fragment is facilitated by IPTG-induced  -Red expression. Step 3: pTKRED is cured by
growth at 42 C and screening against spectinomycin resistance.
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regulation of I-SceI by ParaBAD in the absence of
L-arabinose (28) allows for the maintenance of
pTKRED throughout the entire integration process,
eliminating the need for tedious repeated transformations
with pTKRED.
Finally, the host strain is transformed with the donor
plasmid pTKIP. This plasmid contains the construct to be
inserted ﬂanked by I-SceI endonuclease recognition sites
and the same 25-bp landing pad region contained within
the landing pad. I-SceI expression is induced with
L-arabinose, leading to cleavage of both the donor
plasmid and the chromosome at the site of landing pad
insertion. The incorporation of the insertion fragment into
the landing pad is enhanced by the expression of the
 -Red enzymes and the introduction of double strand
breaks in both the donor and chromosome. After over-
night growth in L-arabinose and IPTG, the majority of
surviving cells expressing the appropriate antibiotic
marker have stably integrated the donor construct. Due
to the small size of the landing pad regions, double-strand
breaks caused by I-SceI cleavage are required for eﬃcient
integration, and the resulting destruction of the I-SceI sites
allows for repeated insertions without the need for addi-
tional constructs containing novel landing pad regions.
Curing the donor plasmid
pTKRED includes a temperature sensitive pSC101 repli-
cation origin. This plasmid is thus easily cured by growth
at 42 C and screening against spectinomycin resistance. Of
more concern is the donor plasmid pTKIP, which is cured
by I-SceI cleavage. To study the eﬃciency and kinetics of
pTKIP curing by I-SceI expression, we transformed
MG1655 with pTKRED and subsequently transformed
the resulting cells with pTKIP-neo or pL451 without
I-SceI recognition sites to serve as a control. These cells
were inoculated into RDM medium containing 0.5% v/v
glycerol, and I-SceI expression was induced by the
addition of 0.2% w/v L-arabinose. Samples were taken
every hour and plated on LB agar with and without
plasmid antibiotic markers to measure the rate and
completeness of plasmid curing. The results are shown in
Figure 3; the curing of pTKIP is very eﬃcient, with only
 1% of cells retaining the donor plasmid.
Large construct insertion in six unique chromosomal
locations
We used the method outlined above to insert a 7-kb
fragment into six unique locations distributed symmetri-
cally about the E. coli replication origin (Figure 4a). The
inserted fragment was a large transcriptional unit
(the IvT-O1Z-neo cassette) constructed on pTKIP-neo
composed of a lacI:venus:T1 translational fusion (22,29)
and a lacZ reporter gene driven by the synthetic LacI
regulated promoter PLlacO1 (21).
Cells with landing pad insertions at each position in
Figure 4a were transformed with the donor plasmid
pTKIP-IvT-O1Z and the insertion of the IvT-O1Z-neo
cassette was performed as described in ‘Materials and
Methods’ section. After insertion, cultures were diluted
Figure 4. (a) Chromosomal insertion positions. Fragments were
inserted into six positions distributed symmetrically about the E. coli
chromosomal origin of replication oriC. Insertion positions are between
the marked genes at each position (dots). (b) Veriﬁcation of chromo-
somal insertions. Colony PCR across insertion junctions for insertion
of the PlacI-lacI:venus:T1-neo cassette (IvT-neo; 2.1-kb band) into the
nth-ydgR position and the PLlacO1-lacZ-cat cassette (O1Z-cat; 5-kb
band) at each site. The insertion of both the IvT-neo and O1Z-cat
cassettes into the nth-ydgR position was accomplished by a single
7-kb insertion bearing the neo marker. Lanes 2–8 are MG1655 lac
negative controls in the following order: lane 2: nth IvT-neo; lanes 3–8:
O1Z in alphabetical order of insertion positions, corresponding to
positive insertion lanes 10–20.
Figure 3. pTKIP is cured by in vivo I-SceI cleavage. Circles indicate
the number of cells retaining pTKRED, squares indicate retention of
pTKIP-neo. Normalized cfu is the ratio of surviving colonies on plates
containing the appropriate antibiotic (100mg/ml spectinomycin and
25mg/ml kanamycin for pTKRED and pTKIP, respectively) to
surviving colonies on LB plates without selection.
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5 , and 100ml was plated on LB agar plates with 0.1%
X-Gal, 2mM IPTG and 25mg/ml kanamycin and
incubated overnight at 37 C. All of the resulting
colonies were blue, and of the colonies picked for
further analysis all showed the proper antibiotic resis-
tances, indicating the insertion of the fragment and loss
of the pTKIP plasmid and tetracycline landing pad. PCR
across the integration junctions veriﬁed successful integra-
tion. Figure 5a shows the result of PCR veriﬁcation of 16
clones after construct insertion at the atpI-gidB intergenic
region.
The products obtained from PCR veriﬁcation of the
atpI-gidB integration junctions were subsequently
sequenced, and the alignment of eight representative
sequences is shown in Figure 5b and c. The correct chro-
mosomal sequence is obtained in the ﬂanking regions,
with the sequence of the integrated fragment ﬂanked by
the 25-bp landing pad regions. The sequence of the
inserted fragment was identically correct for all eight
clones and is not shown in Figure 5b and c for brevity.
The I-SceI sites of both the landing pad and the donor
fragment were eliminated, although in two instances 1 or
2bp ﬂanking the 25-bp landing pad region were incorrect.
Due to the high sequence ﬁdelity of the inserted construct,
we speculate that these isolated mismatches ﬂanking the
25-bp landing pad region are due to imprecise elimination
of the I-SceI sites.
Repeated insertion of constructs at multiple locations
To demonstrate the repeatability of the protocol, we ﬁrst
inserted the IvT-neo cassette into the nth-ydgR intergenic
region. This insertion was veriﬁed via PCR and the
resulting clones were kanamycin resistant. We then
cloned PLlacO1-lacZ into pTKIP-cat and attempted to
insert this O1Z-cat cassette into each of the remaining
positions indicated in Figure 4a. After insertion, the
cultures were diluted 10
5  and plated on LB plates
including X-Gal, 2mM IPTG, 25mg/ml kanamycin and
34mg/ml chloramphenicol. All resulting colonies were
blue, indicating insertion of the O1Z-cat cassette.
Colonies were picked onto LB plates containing
25mg/ml kanamycin and 34mg/ml chloramphenicol,
100mg/ml ampicillin or 10mg/ml tetracycline. All
colonies displayed the correct antibiotic resistances, and
Figure 5. (a) Veriﬁcation of large chromosomal insertions. Colony PCR of 16 randomly picked colonies obtained from insertion of IvT-O1Z-neo
between atpI and gidB. Lane 2: MG1655 lac pTKRED negative control atpI proximal junction. Lane 3: MG1655 lac pTKRED negative control
gidB proximal junction. Lanes 5–20 and 22–37 are IvT-O1Z-neo cassette integrants. Lanes are alternating pairs of atpI proximal junctions (2.1-kb
bands; lacI:venus:T1 ampliﬁed) and gidB proximal junctions (5-kb bands; lacZ-neo ampliﬁed) for each clone. (b, c) Alignment of insertion junction
sequences obtained from ﬁrst eight clones shown in (a). (b) Junction proximal to atpI. (c) Junction proximal to gidB. Sequences of the ﬂanking
chromosomal regions, 25-bp landing pad regions, and the inserted fragment are labeled and indicated by a black, red or purple underscore,
respectively. Mismatches to the expected sequence are highlighted in blue.
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tions are shown in Figure 4b.
Insertion without antibiotic selection
Selection of successful chromosomal integrants of a large
construct is a straightforward process because the inserted
fragment includes a unique antibiotic marker. However,
other studies in which double-strand breaks have been
induced in the E. coli chromosome have shown such
damage to be lethal (30). We, therefore, reasoned that
after induction of chromosomal breaks by I-SceI, success-
ful integration of fragments resulting in chromosomal
repair would provide suﬃcient selective pressure to elim-
inate all but successful integrants from the culture,
eliminating the need for antibiotic selection.
To test the lethality of I-SceI-mediated chromosomal
breaks, landing-pad integrants were inoculated into
RDM medium with 0.5% v/v glycerol, 2mM IPTG and
0.2% w/v L-arabinose. Another tube was prepared in
parallel with identical conditions using MG1655 lac
pTKRED as a control. Samples were taken every hour
and plated on LB plates to measure the viability of the
cells. The results for landing pad integrants in the atpI-
gidB intergenic region (squares) and the essQ-cspB
intergenic region (triangles) are shown in Figure 6. The
growth curves display site-speciﬁc sensitivity to chromo-
somal cleavage, since the growth of atpI-gidB landing pad
integrants is arrested by expression of I-SceI (doubling
time 8.3h), whereas essQ-cspB landing-pad integrants
grow at a signiﬁcantly reduced rate (doubling time 1.5h)
compared to cells with no landing-pad insertion (doubling
time 43min). Colonies grew after replica printing onto low
nutrient fusaric acid plates (25), verifying excision of the
landing pad. We postulate that the ability of cells to
survive in spite of chromosomal cleavage is due to repair
via recombination of the chromosomal break mediated by
overexpression of  -Red enzymes. This hypothesis is sup-
ported by the observation that repeating the above exper-
iment in the absence of IPTG and plating on fusaric acid
LB agar plates results in a complete lack of growth for all
landing-pad integration strains studied thus far. It is,
however, unclear what determines the site-speciﬁcity of
the ability to repair the chromosome.
We next attempted the insertion of the same 7-kb
IvT-O1Z-neo cassette used above without antibiotic selec-
tion. The insertion was performed as above in medium
supplemented with 0.2% L-arabinose with and without
the addition of 2mM IPTG to determine the degree of
enhancement of recombination stimulated by the expres-
sion of  -Red. After overnight growth, cultures were
diluted 10
5  and plated on LB agar plates with 0.1%
X-Gal and 2mM IPTG. The resulting blue/white colony
counts are given in Table 1. In instances where chromo-
somal breaks are lethal (e.g. atpI-gidB and nth-ydgR)
markerless insertion is extremely eﬀective, with  100%
successful integration with or without the addition of
2mM IPTG. However, when the chromosomal break
occurs in non-lethal sites, the insertion statistics are less
favorable. Induction of  -Red increases the eﬃciency of
insertion considerably, with the least eﬀective insertion
position (essQ-cspB) yielding 19.2% successful integrants.
Without the induction of  -Red, the eﬃciency of fragment
insertion drops to 5.9–14.5%.
DISCUSSION
Our protocol allows large fragments to be inserted into
any desired position and orientation in the chromosome.
Our method takes  1.5–2 weeks to accomplish from start
to ﬁnish, which does not include the time required for
engineering the donor plasmid. It should be noted that
due to the requirement to clone the insertion fragment
into a donor plasmid, our method suﬀers from the
general weaknesses inherent in molecular cloning, such
as MCS/insert compatibility.
Here, we have demonstrated a substantial increase in
capacity over previously reported recombineering
attempts (13–16). We have not yet explored the very
upper limits of insertion size. However, our method
bears some resemblance to the ALFIRE method for
BAC subcloning (19), which was shown to allow the
transfer between BACS of large fragments up to 55kb
in size. We think it likely that our method will allow for
the insertion of similarly large constructs into the chromo-
some using a donor BAC. In addition, even considering
the introduction of the two 25-bp landing pad regions, our
method is ‘cleaner’ than phage-derived insertion strategies
(12,17), which generally result in integration of the entire
donor plasmid into the phage attachment site.
Consequently, many extraneous features, such as the
plasmid replication origin, are inserted along with the
desired fragment. Our method, in contrast, results in
only the insertion of the homology region-ﬂanked
fragment, the sequence of which can be controlled pre-
cisely. In instances where the landing pad sequences
cannot be tolerated, or exact replacement is required, the
landing pad and donor plasmid can be modiﬁed to use the
appropriate chromosomal sequences as the necessary
landing pad regions. For applications, such as the one
described here, where disruption of the genome is a tan-
gential concern, the introduction of these sequences is
Figure 6. I-SceI-induced chromosomal breaks are not lethal in the
presence of  -Red. Solid lines are linear regression ﬁts used to calculate
doubling time. Circles: MG1655 lac pTKRED without landing pad,
doubling time 43min; triangles: essQ-cspB landing pad insertion,
doubling time 1.5h; squares: atpI-gidB landing pad insertion,
doubling time 8.3h.
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the standardized sequences in our view outweighs the
repeated modiﬁcation of the donor and landing pad that
would be necessary to eliminate these scars.
A potential problem with the sequential use of the
standardized landing pad regions is that repeated inser-
tions into the same strain could lead to replacement of
previously inserted fragments. The 25-bp size of the
landing pad regions was chosen speciﬁcally to reduce the
eﬃciency of  -Red mediated homologous recombination
1000–10000  below that obtained with larger (>40bp)
homology regions (7). This reduction in recombination
eﬃciency reduces the eﬃciency of replacement of
previously inserted fragments via homologous recombina-
tion at the standardized landing pad regions. The use of
I-SceI to introduce double-strand breaks in the landing
pad and donor increases the eﬃciency of recombination
at these sites by  5000  (18). In addition, the mainte-
nance of selective pressure by incubating the cells in the
presence of the appropriate antibiotics ensures retention
of all inserted fragments.
We have also shown that in many instances it is possible
to perform markerless insertion. If an identiﬁable reporter
gene is being inserted (such as lacZ in our case), successful
integrants can be easily recognized without antibiotic
selection. In all of the cases studied here, when recombi-
nation of the insertion fragment is enhanced by the induc-
tion of  -Red, the percentage of successful integrants is
 20% or greater. It therefore seems that even without an
easily identiﬁable reporter, successful integrants can be
found via hybridization or with a limited number of
PCR screens. In such cases, and if the landing pad
regions are altered to coincide with the desired integration
site, it should be possible to insert very large fragments
into the chromosome without any additional extraneous
sequence. The internal boundaries of landing pad regions
1 and 2 are marked by KpnI and BclI restriction sites; in
such cases where markerless insertion is desired, the
construct can be cloned between these two sites, leaving
little extraneous sequence to serve as potential competing
recombination targets upon subsequent application of the
method.
For routine chromosomal insertion, we have con-
structed a set of donor plasmids expressing a variety of
easily selectable antibiotic markers. These markers are
ﬂanked by FRT recombination sites and, after insertion,
they can be easily removed via the expression of FLP
recombinase. Since an intact 82–85-bp FRT site is left as
a scar after excision of the marker (6), care must be taken
in performing multiple repeated insertions in close prox-
imity, as expression of FLP can result in the excision of
the entire intervening region.
The in vivo cleavage of the donor plasmids by I-SceI
expression has many advantages over introduction of
linear DNA fragments by direct transformation. The rep-
lication of the donor plasmid is subject to the repair and
editing mechanisms employed by the cell during chromo-
somal and plasmid replication, allowing for higher ﬁdelity
replication of the desired fragment than can be achieved
by PCR (20). In addition, the transformation of
supercoiled donor plasmid is highly eﬃcient, and mainte-
nance of relatively high plasmid copy numbers ( 50
copies for the pMB1 origin used in pTKIP) allows for
the maintenance of a much higher intracellular fragment
concentration than can be achieved by transformation
with linear PCR fragments.
The stable integration of synthetic constructs into any
desired chromosomal site should prove useful, for
example, in cases where the multi-copy dosage resulting
from plasmids is problematic, or where measurements
with precision greater than plasmid copy number noise
will allow are required. We believe that extension of this
method should prove straightforward; we are currently
attempting to adapt the system to other microorganisms
and to apply the method to study the impact of
prokaryotic chromosomal organization on gene
expression.
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Table 1. Selectionless insertion statistics for insertion of the 7-kb
IvT-O1Z-neo cassette at the indicated positions
Insertion location IPTG
( -Red induction)
Total
(blue/white)
% Integrants
atpI-gidB + 705/4 99.4
  1010/44 95.8
yieN-trkB + 642/15 97.7
  461/163 73.9
ygcE-ygcF + 39/100 28.6
  184/1084 14.5
ybbd-ylbG + 178/133 57.2
  354/2295 13.4
nth-ydgR + 191/0 100
  362/16 95.8
essQ-cspB + 377/1583 19.2
  43/685 5.9
Samples were plated on LB agar plates +0.1% X-Gal, 2mM IPTG
without antibiotic selection; these plates were replica printed onto LB
agar plates with 25mg/ml kanamycin, 100mg/ml ampicillin or 10mg/ml
tetracycline.
% integrants: the number of blue colonies displaying appropriate
antibiotic sensitivities divided by total number.
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